Drug Trial Radar · NCT02373137
Descemet Endothelial Thickness Comparison Trial
Last checked: Nov 20, 2026Latest source record: Nov 25, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
38
Actual
Start
Jan 22, 2015
Primary completion
Apr 4, 2018
Study completion May 30, 2023
Sponsor
- Lead sponsor
- Oregon Health and Science UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- University of California, San Francisco; Stanford University
- First posted
- Feb 26, 2015
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare visual acuity outcomes of two types of endothelial keratoplasty: 1) Ultrathin Descemet's Stripping Endothelial Keratoplasty (DSAEK) or 2) Descemet's Membrane Endothelial Keratoplasty (DMEK). Half of the participants will be randomized to have DSAEK and the other half will have DMEK.
Conditions
- Keratoplasty
- Grafting, Corneal
- Transplantation, Corneal
- Transplantation, Cornea
- Keratoplasty, Lamellar
Interventions
DSAEKProcedure
DMEKProcedure
EndoserterDevice
The Endoserter, a corneal endothelium device, is an approved FDA device. This will be used to insert and position the graft into the anterior chamber during endothelial replacement surgery. It is a sterile, single-use instrument.
PrednisoloneDrug
Prednisolone is a corticosteroid used to alleviate swelling post-surgery.
OfloxacinDrug
Ofloxacin is an antibiotic used to treat bacterial infections of the eye.
TropicamideDrug
Tropicamide is a prescription drug used to dilate pupils during an eye exam.
PhenylephrineDrug
Phenylephrine is a prescription drug used to dilate pupils during an eye exam.
Jones TubeDevice
The Jones Tube will be used to insert the graft into a 3.5 mm corneal incision during endothelial replacement surgery.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Best Spectacle-Corrected Visual AcuityTime frame: 6 months
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Byers Eye Institute, Stanford University
Palo Alto, California
F. I. Proctor Foundation, University of California, San Francisco
San Francisco, California
Casey Eye Institute, Oregon Health & Science University
Portland, Oregon
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.